748 related articles for article (PubMed ID: 28567700)
1. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
2. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
[TBL] [Abstract][Full Text] [Related]
3. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
[TBL] [Abstract][Full Text] [Related]
5. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
6. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
[TBL] [Abstract][Full Text] [Related]
7. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
9. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
[TBL] [Abstract][Full Text] [Related]
10. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
11. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
Abdel-Wahab M; Zahn R; Gerckens U; Linke A; Sievert H; Schäfer U; Kahlert P; Hambrecht R; Sack S; Hoffmann E; Senges J; Schneider S; Richardt G;
Heart; 2014 Aug; 100(16):1250-6. PubMed ID: 24895354
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
[TBL] [Abstract][Full Text] [Related]
13. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
14. The interaction of forced expiratory volume in 1 s and N-terminal pro-B-type natriuretic peptide with outcomes after transcatheter aortic valve replacement.
Crestanello JA; Greason KL; Mathew J; Eleid MF; Nkomo VT; Rihal CS; Bagameri G; Holmes DR; Pislaru SV; Sandhu GS; Lee AT; King KS; Alkhouli M
Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36645236
[TBL] [Abstract][Full Text] [Related]
15. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
[TBL] [Abstract][Full Text] [Related]
16. Recovery of left ventricular mechanics after transcatheter aortic valve implantation: effects of baseline ventricular function and postprocedural aortic regurgitation.
Poulin F; Carasso S; Horlick EM; Rakowski H; Lim KD; Finn H; Feindel CM; Greutmann M; Osten MD; Cusimano RJ; Woo A
J Am Soc Echocardiogr; 2014 Nov; 27(11):1133-42. PubMed ID: 25125314
[TBL] [Abstract][Full Text] [Related]
17. The Determinants and Outcomes of Myocardial Injury After Transcatheter Aortic-Valve Implantation: SAPIEN 3 Study.
Sato T; Aizawa Y; Yuasa S; Taya Y; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
Cardiovasc Revasc Med; 2020 Aug; 21(8):973-979. PubMed ID: 31924486
[TBL] [Abstract][Full Text] [Related]
18. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
Chen S; Redfors B; O'Neill BP; Clavel MA; Pibarot P; Elmariah S; Nazif T; Crowley A; Ben-Yehuda O; Finn MT; Alu MC; Vahl TP; Kodali S; Leon MB; Lindman BR
Eur Heart J; 2020 Feb; 41(8):958-969. PubMed ID: 31883339
[TBL] [Abstract][Full Text] [Related]
19. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Recovery of Reduced Left Ventricular Ejection Fraction after Aortic Valve Replacement in Patients with Bicuspid Aortic Valve Disease.
Disha K; Espinoza A; Rouman M; Secknus MA; Kuntze T; Girdauskas E
Thorac Cardiovasc Surg; 2016 Aug; 64(5):418-26. PubMed ID: 26251215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]